Quick Answer
Clearmind Medicine Inc. reported Research And Development Expense of $2.06 million for the year ending 2025.
- Clearmind Medicine Inc. showed an increase of +48.7% in Research And Development Expense from 2024 to 2025.
- This data is from Clearmind Medicine Inc.'s annual report (Form 10-K), filed with the SEC on January 20, 2026.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 5 years of available data (2021 to 2025), Clearmind Medicine Inc.'s Research And Development Expense has grown by 334.2%.
- Historical annual values: Fiscal year 2025: $2.06 million | Fiscal year 2024: $1.38 million | Fiscal year 2023: $1.54 million | Fiscal year 2022: $3.08 million | Fiscal year 2021: $473.7 thousand.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: